SCHEMBL2286231

SCHEMBL2286231

COCCc1c[nH]cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7977259 0.88 TLR7 (0.36)
SCHEMBL15114760 0.85
SCHEMBL7977343 0.82 HRH3 (0.32)
SCHEMBL23119192 0.79
SCHEMBL7994249 0.79
SCHEMBL1145591 0.78
SCHEMBL7971472 0.78 HRH3 (0.48)
SCHEMBL30944141 0.76 HTT (0.38)
SCHEMBL326787 0.76
SCHEMBL278546 0.75 NOS3 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086383-A1 SELECT KRAS G12C INHIBITORS AND USES THEREOF 1200 PHARMA LLC (US) 2023-05-19 WO disclosed
US-10266514-B2 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds CELGENE CORPORATION (US) 2019-04-23 US disclosed
US-20180044318-A1 PROCESSES FOR THE PREPARATION OF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE COMPOUNDS CELGENE CORP (US) 2018-02-15 US disclosed
US-9822093-B2 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds CELGENE CORPORATION (US) 2017-11-21 US disclosed
US-20160297791-A1 PROCESSES FOR THE PREPARATION OF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE COMPOUNDS CELGENE CORP (US) 2016-10-13 US disclosed
US-9394274-B2 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds CELGENE CORPORATION (US) 2016-07-19 US disclosed
CN-102643267-B The preparation method of 4-amino-2-(2,6-dioxopiperidin-3-base) isoindoline-1,3-dione compounds CELGENE CORP. (US) 2015-09-16 CN disclosed
US-20140256950-A1 PROCESSES FOR THE PREPARATION OF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE COMPOUNDS CELGENE CORPORATION (US) 2014-09-11 US disclosed
US-8785644-B2 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds CELGENE CORPORATION (US) 2014-07-22 US disclosed
EP-2380887-B1 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds CELGENE CORP (US) 2013-08-07 EP disclosed
EP-1907373-B1 PROCESSES FOR THE PREPARATION OF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE COMPOUNDS CELGENE CORP (US) 2013-01-09 EP disclosed
CN-102643267-A Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds CELGENE CORP 2012-08-22 CN disclosed
CN-101253163-B Process for preparing 4-amino-2- (2, 6-dioxopiperidin-3-yl) isoindoline-1, 3-dione compounds CELGENE CORP 2012-05-02 CN disclosed
EP-2380887-A1 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds Celgene Corporation (US) 2011-10-26 EP disclosed
US-20110224440-A1 PROCESSES FOR THE PREPARATION OF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE COMPOUNDS CELGENE CORPORATION 2011-09-15 US disclosed
US-7994327-B2 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds CELGENE CORPORATION (US) 2011-08-09 US disclosed
CN-101253163-A Process for preparing 4-amino-2- (2, 6-dioxopiperidin-3-yl) isoindoline-1, 3-dione compounds CELGENE CORP (US) 2008-08-27 CN disclosed
EP-1907373-A1 PROCESSES FOR THE PREPARATION OF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE COMPOUNDS CELGENE CORPORATION (US) 2008-04-09 EP disclosed
WO-2007005972-A1 PROCESSES FOR THE PREPARATION OF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE COMPOUNDS CELGENE CORPORATION (US) 2007-01-11 WO disclosed
US-20070004920-A1 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds CELGENE CORPORATION AN ORGNIZATION OF THE STATE NEW JERSEY (US) 2007-01-04 US disclosed